Stanford University other research news

Stanford researchers reported in the Proceedings of the National Academy of Sciences that they have developed a method for introducing genetically engineered genes into cells and controlling their protein output with tetracycline. The technique builds on earlier work in a tetracycline-driven system that required a lengthy, two-step procedure to deliver all the necessary components.

The new technique uses a retrovirus, allowing delivery of genes into cell types that are difficult to transfect, such as muscle cells and lymphocytes, at efficiencies as high as 95 percent and 40 percent, respectively. ...